Repligen Corporation to Present at Upcoming September Conferences

Rhea-AI Summary

Repligen Corporation (NASDAQ:RGEN), a bioprocessing technology leader in life sciences, has announced its participation in three major healthcare conferences in September 2025:

• Wells Fargo Healthcare Conference (Sept 3-5, Boston) - CEO Olivier Loeillot to join analyst discussion on Sept 4 at 8:00 a.m. ET
• Deutsche Bank Healthcare Summit (Sept 10-11, NYC) - CFO Jason Garland to hold 1x1 meetings on Sept 10
• Bank of America Global Healthcare Conference (Sept 23-25, London) - CEO Olivier Loeillot to participate in analyst discussion on Sept 25 at 6:35 a.m. ET

Live webcasts will be available on Repligen's Investor Relations website with limited-time replay access.

News Market Reaction

+4.30%

1 alert

+4.30% News Effect

On the day this news was published, RGEN gained 4.30%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending three upcoming investor conferences.

• The Wells Fargo Healthcare Conference, being held September 3 – 5 in Boston. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst led discussion at 8:00 a.m. ET on Thursday, September 4, 2025.
• The Deutsche Bank Healthcare Summit, being held September 10 – 11 in New York. Jason Garland, Chief Financial Officer, will participate in 1x1 meetings on September 10.
• The Bank of America Global Healthcare Conference, being held September 23 – 25 in London, UK. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst led discussion at 6:35 a.m. ET/11:35 a.m. British Summer Time on Thursday, September 25, 2025.
  

A live webcast of the conference presentations will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.

About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the our company see our website at www.repligen.com, and follow us on LinkedIn.

Repligen Contact:
Jacob Johnson
VP, Investor Relations
781-419-0204
investors@repligen.com 

FAQ

When is Repligen (NASDAQ:RGEN) presenting at the Wells Fargo Healthcare Conference 2025?

Repligen's CEO Olivier Loeillot will participate in an analyst-led discussion at 8:00 a.m. ET on Thursday, September 4, 2025 at the Wells Fargo Healthcare Conference in Boston.

Who will represent Repligen at the Deutsche Bank Healthcare Summit 2025?

Jason Garland, Chief Financial Officer of Repligen, will participate in one-on-one meetings on September 10, 2025, at the Deutsche Bank Healthcare Summit in New York.

What time is Repligen's presentation at the Bank of America Global Healthcare Conference 2025?

CEO Olivier Loeillot will present at 6:35 a.m. ET/11:35 a.m. British Summer Time on Thursday, September 25, 2025 in London.

How can investors access Repligen's conference presentations?

Investors can access the live webcasts through Repligen's Investor Relations website at www.repligen.com. Replays will be available for a limited time after each event.